Visual acuity (VA), the cornerstone of eyecare, can yield symptoms despite 20/20 [1]. Optimal VA is 20/10 based on cone spacing. Vernier acuity (minimum misalignment) is 3” arc, 10x < cone spacing, a hyperacuity mediated by visual cortex [2,3,4]. Minimum visible acuity [2] (MVA, thinnest black line detectable on white background) is 1” arc. Hence MVA (pilot avoiding fine wire), is a potential hyperacuity never used clinically. We describe a cone specific test of MVA, including monocular, binocular, chromatic, and orientation specific performance.
Twenty-five healthy young adults (VA ≥ 20/30, mean age ± SD: 26 ± 3, 13 females) participated in our IRB approved protocol after written informed consent. MVA stimuli were 1.4° vertical, horizontal, or oblique (45°, 135°) lines centered on a Microsoft Surface display (3.7° x 2.1°) at 4 m in a dark room. Each line was an increase in red (L), green (M), blue (S) cone or luminance (grey) against a grey background (24.7 cd/m2, x, y = 0.318, 0.355) limiting stimulation to each pathway based on chromaticity and luminance [5]. Contrasts 16%: L, M, luminance; 128%: S cones due to sparse distribution and lower CS [5]. Line thicknesses varied from 60” to 10” arc in 0.16 log steps (16 stimuli/thickness level, 4 orientations, 4 colors). Each trial consisted of a single line centered on the display wherein subjects identified stimulus orientation and color (0.01 log units/trial, Fig. 1a). Contrast, orientation, eye tested were randomized across trials. Binocular followed monocular to minimize learning. Monocular (P > 0.18) and binocular (P > 0.47) MVA log thresholds were distributed normally (Jarque–Berra test). Repeated-measures ANOVA, paired t-tests (Bonferroni correction) and Bland-Altman were used for analyses.
A MVA Displays. MVA maximum thickness stimuli shown for luminance (grey, upper left), L cone (red-orange, lower left), M cone (green, upper right), and S cone (purple, lower right). On each trial a single line with specific color and orientation appeared. Subjects reported both orientation and color. Sixteen stimuli appeared at each thickness level which varied in 0.16 log steps affording a precision of .01 log units per trial. B Coefficient of repeatability (COR). The COR is the 95% confidence interval for within patient change, critical for a new test. For a single patient, values falling outside the COR on a second measure indicates significant change. To estimate the COR, the Bland Altman plot shows the difference between right and left eyes (across all colors) plotted against their respective means. The mean difference was zero indicating no bias (between right and left eyes) and 2 SD above and below the mean difference is the COR, which is 0.3 or only 2” of arc indicating a repeatable test.
Repeated measures ANOVA across eye tested and cone type showed significant effects of eye (F = 15.5, P < 0.001) and cone type (F = 50.8, P < 0.001). Since MVA was not different between right and left eyes (P > 0.73) means were used for monocular analyses. The coefficient of repeatability, 95% confidence interval (CI) for within-patient change, was 0.3 log thickness (2” arc, Bland Altman, Fig. 1b). Across all colors, mean binocular threshold (1.12 log s, 13”) was significantly lower than monocular (1.30, 20”, mean difference 0.18 log s, 95% CI 0.16–0.20, P < 0.001, Fig. 2a). There was no difference between L, M and grey MVA thresholds (P > 0.32) while both S cone monocular MVA (1.40) was reduced vs. L, M, luminance (1.26, mean difference 0.14, 95% CI 0.09–0.17, P < 0.001) as was S cone binocular MVA (difference 0.08, 95% CI 0.04–0.13, P < 0.001, Fig. 2b). Binocular S cone MVA was decreased for oblique vs. horizontal/vertical (P < 0.02). Binocular L cone MVA was improved for horizontal compared to vertical (P < 0.001).
A Binocular Enhancement. Mean (±1SE, across all colors) monocular and binocular MVA thresholds (sec. of arc) show a significantly lower binocular threshold (50%, higher sensitivity with two eyes vs. one) than the classical finding of 40% for contrast sensitivity. B Cone Specific MVA. Mean (±1SE) monocular and binocular MVA thresholds for luminance, L, M, and S cone pathways showing binocular enhancement (lower binocular thresholds for each pathway) with significantly higher thresholds for S cones attributable to their sparse distribution and lower contrast sensitivity [5].
MVA binocular and orientation effects support cortical processing. Decreased S cone MVA reflects the paucity of S cones. 50% enhancement of binocular vs. monocular MVA exceeds 40% for CS indicating binocular cortical processing. Improved L cone binocular horizontal MVA may increase disparity enhancing stereoacuity. MVA shows promise for disease detection/monitoring, occupational application, and as an outcome for gene therapy. Ongoing research is assessing age, orientation, and color naming. Preliminary results show high sensitivity for detection of color deficiency and improvement with color correcting lenses.
References
Rabin J, Gooch J, Ivan D, Harvey R, Aaron M. Beyond 20/20: new clinical methods to quantify vision performance. Mil Med 2011;176:324–6. https://doi.org/10.7205/milmed-d-10-00320
Westheimer G. The spatial sense of the eye. Proctor lecture. Investig Ophthalmol Vis Sci. 1979;18:893–912.
Levi DM, Polat U, Hu YS. Improvement in vernier acuity in adults with amblyopia. Practice makes better. Investig Ophthalmol Vis Sci. 1997;38:1493–510.
Hu M, Ayton LN, Jolly JK. The clinical use of vernier acuity: resolution of the visual cortex is more than meets the eye. Front Neurosci. 2021;15:714843. https://doi.org/10.3389/fnins.2021.714843
Rabin J, Gooch J, Ivan D. Rapid quantification of color vision: the Cone Contrast Test. Investig Ophthalmol Vis Sci 2011;52:816–20. https://doi.org/10.1167/iovs
Funding
Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Award Number T35EY032441. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Open access funding provided by SCELC, Statewide California Electronic Library Consortium.
Author information
Authors and Affiliations
Contributions
JR was responsible for designing the protocol, data collection, results interpretation and analyses, manuscript writing, and research oversight. KG, AH, CD, KD, DB, and TT were responsible for designing the protocol, data collection, collating data, data curation, results interpretation and analyses. Contributions and access to data: The Principal Investigator, Jeff Rabin, had full access to all data and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rabin, J., Goodroe, K., Hood, A. et al. Minimum visual acuity: a new cone specific clinical test. Eye 39, 195–197 (2025). https://doi.org/10.1038/s41433-024-03377-7
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-024-03377-7

